Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (431-440 of 1,248) with videos related to

Pageof 125
Sort By:
Journal of Clinical Pharmacology|February 1, 1976
Serum creatine phosphokinase concentrations after intramuscular chlordiazepoxide and its solventD J Greenblatt, R I Shader, J Koch-Weser
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2000
CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitorK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of the Maine Medical Association|May 1, 1975
Pharmacotherapy of essential hypertensionD W Duhme, D J Greenblatt, R R Miller
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrateK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolismE Störmer, L L von Moltke, D J Greenblatt
Journal of Clinical Psychopharmacology|August 1, 1994
Thinking while balancing: what to do about replacing dropoutsR I Shader, J S Harmatz, D J Greenblatt
The American Journal of Psychiatry|February 1, 1980
Overdosage with antipsychotic agentsM D Allen, D J Greenblatt, B J Noel
Clinical Pharmacokinetics|January 14, 2010
Effect of obesity on the pharmacokinetics of drugs in humansMichael J Hanley, Darrell R Abernethy, David J Greenblatt
The New England Journal of Medicine|August 18, 1983
Drug therapy. Current status of benzodiazepinesD J Greenblatt, R I Shader, D R Abernethy
Journal of Clinical Psychopharmacology|December 8, 2017
Update on Psychotropic Drug Prescribing in the United States: 2014-2015David J Greenblatt, Jerold S Harmatz, Richard I Shader
Pageof 125

Showing results (431-440 of 1,248) with videos related to

Sort By:
Pageof 125
Journal of Clinical Pharmacology|February 1, 1976
Serum creatine phosphokinase concentrations after intramuscular chlordiazepoxide and its solventD J Greenblatt, R I Shader, J Koch-Weser
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2000
CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitorK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of the Maine Medical Association|May 1, 1975
Pharmacotherapy of essential hypertensionD W Duhme, D J Greenblatt, R R Miller
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrateK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolismE Störmer, L L von Moltke, D J Greenblatt
Journal of Clinical Psychopharmacology|August 1, 1994
Thinking while balancing: what to do about replacing dropoutsR I Shader, J S Harmatz, D J Greenblatt
The American Journal of Psychiatry|February 1, 1980
Overdosage with antipsychotic agentsM D Allen, D J Greenblatt, B J Noel
Clinical Pharmacokinetics|January 14, 2010
Effect of obesity on the pharmacokinetics of drugs in humansMichael J Hanley, Darrell R Abernethy, David J Greenblatt
The New England Journal of Medicine|August 18, 1983
Drug therapy. Current status of benzodiazepinesD J Greenblatt, R I Shader, D R Abernethy
Journal of Clinical Psychopharmacology|December 8, 2017
Update on Psychotropic Drug Prescribing in the United States: 2014-2015David J Greenblatt, Jerold S Harmatz, Richard I Shader
Pageof 125